Sympathomimetic agent and antihistamine

This page covers all Sympathomimetic agent and antihistamine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Alpha-adrenergic receptor (alpha-1 adrenergic receptor) and H1 receptor.

Targets

Alpha-adrenergic receptor (alpha-1 adrenergic receptor) and H1 receptor

Phase 3 pipeline (1)

• Naphazoline hydrocloride + Pheniramine Maleate + Panthenol · EMS · Ophthalmology
  Naphazoline hydrochloride is a sympathomimetic agent that acts as an alpha-adrenergic agonist, while pheniramine maleate is an antihistamine that exerts its effects by competitively inhibiting the action of histamine at the H1 receptor. Panthenol, a form of vitamin B5, has moisturizing and soothing properties.

Patent intelligence

• sympathomimetic agent and antihistamine patent landscape — aggregated cliff calendar, attackable patents, originator estates